The average one-year price target for Lifeward (NasdaqCM:LFWD) has been revised to $20.40 / share. This is an increase of 344.44% from the prior estimate of $4.59 dated February 21, 2026. The price ...

Lifeward Ltd. (NASDAQ:LFWD) reported weaker-than-expected results for the fourth quarter of fiscal 2025, with both earnings ...

Medical device manufacturer Lifeward in Marlborough has regained compliance with Nasdaq listing requirements a month after receiving notice it risked delisting. Lifeward maintained the required ...

Lifeward (NASDAQ:LFWD) shares fell 11% premarket on Tuesday after the company announced an offering to raise $5M in gross proceeds to support continuing commercial efforts. The company entered into a ...

Lifeward Ltd. (NASDAQ:LFWD) stock is trading higher on Thursday after the company announced that its ReWalk 7 received 510(k) clearance from the Food and Drug Administration (FDA). What To Know: The ...

Lifeward Ltd. is a listed company whose ordinary shares trade on The Nasdaq Capital Market under the ticker symbol LFWD. The company is subject to Nasdaq’s corporate governance and audit committee ...

Lifeward, Ltd., a leader in innovative medical technology for individuals with physical limitations, announced that CEO Larry Jasinski and CFO Mike Lawless will present at the Sidoti May Virtual ...

HUDSON, Mass. and YOKNEAM ILLIT, Israel - Lifeward Ltd. (NASDAQ:LFWD) announced today that its shareholders approved the issuance of ordinary shares in connection with its strategic partnership with ...

HUDSON, Mass. and YOKNEAM ILLIT, Israel, March 11, 2026 (GLOBE NEWSWIRE)-- Lifeward Ltd. (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global leader in innovative medical technology to transform the ...

Lifeward Ltd. (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global leader in innovative medical technology to transform the lives of people with physical limitations or disabilities, today announced ...